BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26507306)

  • 1. Counterpoint: epidemiology to guide decision-making: moving away from practice-free research.
    Hernán MA
    Am J Epidemiol; 2015 Nov; 182(10):834-9. PubMed ID: 26507306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vandenbroucke and Pearce respond to "incident and prevalent exposures and causal inference".
    Vandenbroucke J; Pearce N
    Am J Epidemiol; 2015 Nov; 182(10):846-7. PubMed ID: 26507304
    [No Abstract]   [Full Text] [Related]  

  • 4. A Future for Observational Epidemiology: Clarity, Credibility, Transparency.
    Harper S
    Am J Epidemiol; 2019 May; 188(5):840-845. PubMed ID: 30877294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship-Observational Studies.
    Snyder GM; Young H; Varman M; Milstone AM; Harris AD; Munoz-Price S
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1141-6. PubMed ID: 27322190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The limitations of observation studies for decision making regarding drugs efficacy and safety.
    Gueyffier F; Cucherat M
    Therapie; 2019 Apr; 74(2):181-185. PubMed ID: 30514576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confounding in health research.
    Greenland S; Morgenstern H
    Annu Rev Public Health; 2001; 22():189-212. PubMed ID: 11274518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterpoint: the treatment decision design.
    Brookhart MA
    Am J Epidemiol; 2015 Nov; 182(10):840-5. PubMed ID: 26507307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches.
    Little RJ; Rubin DB
    Annu Rev Public Health; 2000; 21():121-45. PubMed ID: 10884949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the causal structure of information bias and confounding bias in randomized trials.
    Shahar E; Shahar DJ
    J Eval Clin Pract; 2009 Dec; 15(6):1214-6. PubMed ID: 20367730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What are the propensity scores?].
    Ojeda D; Gómez R; Burgos Á
    Rev Med Chil; 2016 Mar; 144(3):364-70. PubMed ID: 27299823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research.
    Targownik LE; Suissa S
    Am J Gastroenterol; 2015 Dec; 110(12):1647-50. PubMed ID: 26323186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From observational studies to randomized trials: asking the right question at the right time.
    Neaton JD; Mugglin AS
    J Clin Periodontol; 2006 Aug; 33(8):517-9. PubMed ID: 16899092
    [No Abstract]   [Full Text] [Related]  

  • 14. Point: incident exposures, prevalent exposures, and causal inference: does limiting studies to persons who are followed from first exposure onward damage epidemiology?
    Vandenbroucke J; Pearce N
    Am J Epidemiol; 2015 Nov; 182(10):826-33. PubMed ID: 26507305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causal proportional hazards models and time-constant exposure in randomized clinical trials.
    Loeys T; Goetghebeur E; Vandebosch A
    Lifetime Data Anal; 2005 Dec; 11(4):435-49. PubMed ID: 16328570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bounds on potential risks and causal risk differences under assumptions about confounding parameters.
    Chiba Y; Sato T; Greenland S
    Stat Med; 2007 Dec; 26(28):5125-35. PubMed ID: 17525935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Observational studies: the hazard and other gods].
    Arenas-Fernández J; Fernández-Martín JL; Cannata-Andía JB; Martínez-Camblor P
    Med Clin (Barc); 2014 Jan; 142(2):80-4. PubMed ID: 23831405
    [No Abstract]   [Full Text] [Related]  

  • 18. Observational research--opportunities and limitations.
    Boyko EJ
    J Diabetes Complications; 2013; 27(6):642-8. PubMed ID: 24055326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stopping trials for efficacy: an almost unbiased view.
    Goodman SN
    Clin Trials; 2009 Apr; 6(2):133-5. PubMed ID: 19342465
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction and causal inference.
    Gagliardi L
    Acta Paediatr; 2009 Dec; 98(12):1890-2. PubMed ID: 20050836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.